Clinical Trial Update: S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for Advanced Gastric Cancer [Phase 3]

View source ↗

Summary

This ClinicalTrials.gov entry documents a completed Phase 3 trial comparing S-1 plus cisplatin given every 3 weeks to S-1 plus oxaliplatin in patients with adva…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Min-Hee Ryu | Conditions: Gastric Cancer | Phase 3 | Status: COMPLETED